文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛复苏、休克与脓毒症

重症监护病房中的军团菌肺炎:一家三级医疗中心10年经验

Legionella Pneumonia in the ICU: A Tertiary Care Center Experience Over 10 Years.
PubMed 文献 · Crit Care Explor · 2021-08-10
一句话结论军团菌肺炎重症患者常需器官支持,30天死亡率为26.1%;入院24小时内未接受军团菌特异性抗菌治疗是死亡预测因素,作者认为重症肺炎经验性方案应包含军团菌靶向抗生素。

该回顾性观察研究纳入了2010年1月1日至2019年12月31日期间在某三级教学医院ICU住院的88例成人军团菌肺炎患者。90.9%为社区获得性感染,ICU入科时SOFA评分中位数6分,70.5%需有创机械通气,64.8%发生脓毒性休克,47.7%发生急性呼吸窘迫综合征,78.4%发生急性肾损伤。10例接受静脉-静脉体外膜氧合支持,其中8例(80%)存活并成功撤机;总体30天死亡率为26.1%(23例)。高龄、入科时较高SOFA评分及入院24小时内未接受军团菌特异性抗菌治疗是30天死亡的预测因素。

要点

  • 88例ICU军团菌肺炎患者中,30天死亡率为26.1%(23例);高龄、入科时较高SOFA评分及入院24小时内未接受军团菌特异性抗菌治疗是30天死亡的预测因素。
  • ICU入科时SOFA评分中位数为6分(四分位距3-9分),70.5%(62例)需有创机械通气,64.8%(57例)发生脓毒性休克,47.7%(42例)发生急性呼吸窘迫综合征。
  • 急性肾损伤发生于78.4%(69例)患者,其中21.7%(15例)仅接受间歇性血液透析,21.7%(15例)需连续性肾脏替代治疗。
  • 10例需静脉-静脉体外膜氧合支持,其中8例(80%)存活并成功撤机。
  • 作者认为,任何重症肺炎患者的经验性方案均应包含军团菌靶向抗生素;该人群中体外膜氧合治疗结局令人鼓舞。

适用人群与场景

  • 2010年1月1日至2019年12月31日期间入住某三级教学医院ICU的成人(≥18岁)军团菌肺炎患者,共88例;90.9%(80例)为社区获得性感染。

研究设计与关键结果

  • 回顾性观察研究,共纳入88例ICU军团菌肺炎成人患者;中位年龄60岁(四分位距51.5-71.0岁),66%(58例)为男性,46.6%(41例)自我认定为黑人。
  • ICU入科时SOFA评分中位数为6分(四分位距3-9分);感染呈季节性分布,86%的病例发生于夏季至初秋(5月至10月)。
  • 70.5%(62例)需有创机械通气,64.8%(57例)发生脓毒性休克,47.7%(42例)发生急性呼吸窘迫综合征。
  • 78.4%(69例)发生急性肾损伤,其中21.7%(15例)仅接受间歇性血液透析,21.7%(15例)需连续性肾脏替代治疗。
  • 10例需静脉-静脉体外膜氧合支持,其中8例(80%)存活并成功撤机。
  • 总体30天死亡率为26.1%(23例);高龄、入科时较高SOFA评分及入院24小时内未接受军团菌特异性抗菌治疗是30天死亡的预测因素。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,任何重症肺炎患者的经验性方案均应包含军团菌靶向抗生素。
  • 作者认为,该人群中体外膜氧合治疗结局令人鼓舞。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Few studies have reported the complications and outcomes of patients with Legionella pneumonia requiring ICU admission. The objective of our study is to report the clinical course, complications, and 30-day mortality of patients with Legionella pneumonia admitted to the critical care units at our medical center over a 10-year period.

DESIGN: Retrospective observational study.

SETTING: Tertiary care teaching hospital.

PATIENTS: All adult (≥ 18 yr old) patients with Legionella pneumonia admitted to the ICUs from January 1, 2010, to December 31, 2019.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: A total of 88 patients with Legionella pneumonia were admitted to ICUs over the 10-year period. The majority of infections (n = 80; 90.9%) were community acquired. The median (interquartile range) age of patients was 60 years (51.5-71.0 yr); 58 (66%) were male, and 41 (46.6%) identified their race as Black. The median (interquartile range) Sequential Organ Failure Assessment score at ICU admission was 6 (3-9). The distribution of infections showed seasonal dominance with most cases (86%) occurring in the summer to early fall (May to October). Invasive mechanical ventilation was required in 62 patients (70.5%), septic shock developed in 57 patients (64.8%), and acute respiratory distress syndrome developed in 42 patients (47.7%). A majority of patients developed acute kidney injury (n = 69; 78.4%), with 15 (21.7%) receiving only intermittent hemodialysis and 15 (21.7%) requiring continuous renal replacement therapy. Ten patients required venovenous extracorporeal membrane oxygenation support; eight (80%) survived and were successfully decannulated. Overall 30-day mortality was 26.1% (n = 23). Advanced age, higher Sequential Organ Failure Assessment score at admission, and not receiving Legionella-specific antimicrobial therapy within 24 hours of hospital admission were predictors of 30-day mortality.

CONCLUSIONS: Patients with Legionella pneumonia may require ICU admission and major organ support. Legionella-targeted antibiotics should be included in the empiric regimen for any patient with severe pneumonia. Outcomes of extracorporeal membrane oxygenation therapy in this population are encouraging.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Andrea L, Dicpinigaitis PV, Fazzari MJ, et al. Legionella Pneumonia in the ICU: A Tertiary Care Center Experience Over 10 Years. Crit Care Explor. 2021. PMID: 34396145. doi:10.1097/CCE.0000000000000508

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。